Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Vyne Therapeutics Inc (VYNE)

Vyne Therapeutics Inc (VYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vyne Therapeutics Inc 685 ROUTE 202/206 SUITE 301 BRIDGEWATER NJ 08807 USA

www.vynetherapeutics.com P: 800-775-7936

Description:

VYNE Therapeutics Inc. focuses on developing and commercializing therapeutics for dermatology. The company's product pipeline consist FMX103 and FCD105 which are in clinical stage. VYNE Therapeutics Inc., formerly known as Menlo Therapeutics Inc., is based in Bridgewater, New Jersey.

Key Statistics

Overview:

Market Capitalization, $K 41,986
Enterprise Value, $K 11,316
Shares Outstanding, K 14,528
Annual Sales, $ 420 K
Annual Net Income, $ -28,450 K
Last Quarter Sales, $ 100 K
Last Quarter Net Income, $ -6,250 K
EBIT, $ -30,760 K
EBITDA, $ -31,020 K
60-Month Beta 1.26
% of Insider Shareholders 1.80%
% of Institutional Shareholders 83.78%
Float, K 14,266
% Float 98.20%
Short Volume Ratio 0.19

Growth:

1-Year Return -63.40%
3-Year Return -95.61%
5-Year Return -99.40%
5-Year Revenue Growth -96.05%
5-Year Earnings Growth 98.40%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.15 on 05/09/24
Latest Earnings Date N/A
Earnings Per Share ttm -5.28
EPS Growth vs. Prev Qtr 25.00%
EPS Growth vs. Prev Year 91.38%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-18 on 02/13/23

VYNE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -56.75%
Return-on-Assets % -48.81%
Profit Margin % -6,773.81%
Debt/Equity 0.00
Price/Sales 96.97
Price/Cash Flow N/A
Price/Book 0.42
Book Value/Share 5.91
Interest Coverage -1.08
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar